These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. 4'-O-tetrahydropyranyladriamycin has greater antineoplastic activity than adriamycin in various human tumours in vitro. Maehara Y, Sakaguchi Y, Kusumoto T, Kusumoto H, Sugimachi K. Anticancer Res; 1989; 9(2):387-9. PubMed ID: 2751263 [Abstract] [Full Text] [Related]
24. Antitumor activity of (2''R)-4'-O-tetrahydropyranyl adriamycin on human gastric cancer cell lines in vitro and in vivo. Saikawa Y, Kubota T, Kuo TH, Furukawa T, Kase S, Tanino H, Ishibiki K, Kitajima M, Hoffman RM. Anticancer Res; 1994; 14(2A):469-73. PubMed ID: 8017850 [Abstract] [Full Text] [Related]
25. [Appropriate intravesical retention time of pirarubicin concentration based on its level in tumor tissue, anti-tumor effect and side effect in intravesical instillation therapy for bladder tumor]. Kobayashi M, Sugaya Y, Yuzawa M, Ochi M, Morita T, Kobayashi Y, Tokue A, Hara Y. Gan To Kagaku Ryoho; 1998 Sep; 25(11):1771-4. PubMed ID: 9757205 [Abstract] [Full Text] [Related]
26. [Pirarubicin (THP-adriamycin)]. Tsukagoshi S. Gan To Kagaku Ryoho; 1988 Sep; 15(9):2819-27. PubMed ID: 3046496 [Abstract] [Full Text] [Related]
27. [The effect of the microenvironment of head and neck cancers on tumor progression]. Lukits J. Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327 [Abstract] [Full Text] [Related]
30. [Flow cytometric analysis of the effect of THP-adriamycin on the cell cycle traverse of RPMI-8402 cells--comparison with adriamycin]. Takamoto S, Ota K. Gan To Kagaku Ryoho; 1986 May; 13(5):1868-75. PubMed ID: 3707149 [Abstract] [Full Text] [Related]
32. In vitro antitumor activity of 4'-O-tetrahydropyranyladriamycin on human gastric cancer cells. Yamaue H, Tanimura H, Noguchi K, Shono Y, Iwahashi M, Hotta T, Tani M, Tsunoda T, Nishimoto N, Terasawa H, Nakamori M. Anticancer Res; 1996 May; 16(1):243-6. PubMed ID: 8615614 [Abstract] [Full Text] [Related]
33. [Tissue concentration of (2"R)-4'-O-tetrahydropyranyladriamycin in renal cell carcinoma and urinary bladder tumor (second report)]. Masuda H, Hirose J, Ohtawara Y, Suzuki K, Tajima A, Aso Y, Hiramatsu K, Shomura T. Gan To Kagaku Ryoho; 1987 Oct; 14(10):2912-6. PubMed ID: 3662546 [Abstract] [Full Text] [Related]
34. [Cardiotoxicity due to prolonged administration of THP (2"R-4'-O-tetrahydropyranyl-adriamycin)]. Suzuki M, Hirono M, Majima H. Gan To Kagaku Ryoho; 1997 Oct; 24(13):1993-9. PubMed ID: 9350248 [Abstract] [Full Text] [Related]
37. [Effect of (2"R)-4'-O-tetrahydropyranyladriamycin, a new antitumor antibiotic, on the cardiac function of hamsters]. Tone H, Hirano S, Shirai M, Kumagai H, Okajima Y, Wakabayashi T. Jpn J Antibiot; 1986 Feb; 39(2):547-68. PubMed ID: 3712757 [Abstract] [Full Text] [Related]
40. [Pharmacokinetics of adriamycin by bronchial artery infusion for non-small cell bronchogenic carcinoma]. Wang T, Yang H, Wang H. Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):395-8. PubMed ID: 11810771 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]